2-methoxy-1,4-naphthoquinone has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AS; Lim, YM; Ong, JY; Yong, PV | 1 |
| Lin, YH; Wang, YC | 1 |
2 other study(ies) available for 2-methoxy-1,4-naphthoquinone and Adenocarcinoma
| Article | Year |
|---|---|
2-Methoxy-1,4-naphthoquinone (MNQ) induces apoptosis of A549 lung adenocarcinoma cells via oxidation-triggered JNK and p38 MAPK signaling pathways.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cytotoxins; DNA Damage; Humans; Lung Neoplasms; MAP Kinase Kinase 4; MAP Kinase Signaling System; Naphthoquinones; Neoplasm Proteins; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases | 2015 |
Anti-gastric adenocarcinoma activity of 2-Methoxy-1,4-naphthoquinone, an anti-Helicobacter pylori compound from Impatiens balsamina L.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Helicobacter pylori; Humans; Impatiens; Molecular Structure; Naphthoquinones; Reactive Oxygen Species | 2012 |